Skip to main content
Premium Trial:

Request an Annual Quote

Precision Biosciences Receives $3M to Further Develop Genetic Engineering Technology

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Precision Biosciences today said it has been awarded four government grants totaling more than $3 million for further development of its genome engineering technology.

The grants are from the National Institute of Standards and Technology, the US Department of the Treasury, the National Institutes of Health, and the state of North Carolina.

In a statement, Michael Nicholson, director of cell biology at the Durham, N.C., company said Precision Bio is ready to use its Directed Nuclease Editor technology to "address major challenges facing the biomanufacturing industry," and the funds will allow it to refine applications for the technology, in particular applications for cell line engineering.

Using custom-made DNA-cutting enzymes, Precision Bio changes the genetic sequence of a natural genome editing meganuclease to create a custome meganuclease with DNA-recognition and cleavage properties.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.